News Updates
Regenerative medicine: regulatory trends
Source: Pharmaceutical-Technology
The regulatory principles that apply for the clinical development of conventional therapies also apply to regenerative medicines.
Scientists identify small-molecule cocktail to improve stem cell use in research and disease treatments
Source: NIH
Researchers at the National Institutes of Health have devised a four-part small-molecule cocktail that can protect stem cells called induced pluripotent stem cells (iPSCs) from stress and maintain normal stem cell structure and function.
Ortho regenerative technologies announces submission of investigational new drug application for Ortho-R
Source: PR Newswire
Ortho Regenerative Technologies Inc. (CSE: ORTH) (OTC: ORTIF) ("Ortho RTI" or the "Company"), a clinical stage orthobiologics company focused on the development of novel soft tissue repair regenerative technologies
Scientists use specially designed gold nanoparticles to 'seek out' bone stem cells
Source: News Medical Life Sciences
Researchers at the University of Southampton have developed a new way of using nanomaterials to identify and enrich skeletal stem cells - a discovery which could eventually lead to new treatments for major bone fractures and the repair of lost or damaged bone.
Regenerative medicine: industry trends
Source: Pharmaceutical-Technology
Regenerative medicine is a multidisciplinary field that seeks to develop the science and tools that can help repair, augment, replace, or regenerate damaged or diseased human cells, tissues, genes, organs, or metabolic processes, to restore normal function.
New controversy for stem cell therapy that repairs spinal cords
Source: TheGreatCoursesDaily
Stem cell research regularly generates hot debates over its ethics. A new therapy that has repaired the spinal cords of more than a dozen patients is raising eyebrows for both good and bad reasons. Why is stem cell therapy so controversial?
3D systems expands efforts in bioprinting for regenerative medicine
Source: MDDI Online
Driven by progress in its collaboration with United Therapeutics in developing 3D printing systems for solid-organ scaffolds, 3D Systems intends to further develop and commercialize solutions in the regenerative medicine field.
